Search
for

    Sort by

    Research

    990-1000 / 1000+ results
      Androgenetic Alopecia

      research Androgenetic Alopecia

      18 citations, February 2014 in “PubMed”
      Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.
      Treatment Options for Alopecia

      research Treatment Options for Alopecia

      17 citations, August 2015 in “Expert Opinion on Pharmacotherapy”
      The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.
      Alopecia Areata: An Autoimmune Disease Causing Hair Loss

      research Alopecia Areata: An Autoimmune Disease Causing Hair Loss

      16 citations, May 2011 in “Recent Patents on Inflammation & Allergy Drug Discovery”
      Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.
      Interventions for Female Pattern Hair Loss

      research Interventions for Female Pattern Hair Loss

      15 citations, March 2017 in “JAMA Dermatology”
      Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.
      Androgenic Alopecia in Females: Diagnosis and Treatment

      research Androgenic Alopecia in Females: Diagnosis and Treatment

      14 citations, July 1987 in “Dermatologic Clinics”
      The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.